The Role of Autoflorescence Imaging Device in the Evaluation of Bacteria Burden Control
Agata Janowska, M.D1, Giulia Davini, CNP1, Michela Iannone, M.D1, Cristian Fidanzi, M.D1, Riccardo Morganti, M.D2, Marco Romanelli, Ph.D1, and Valentina Dini, Ph.D1
1Department of Dermatology, University of Pisa, Pisa, Italy
2Department of Clinical and Experimental Medicine, Section of Statistic, University of Pisa, Pisa, Italy
The International Journal of Lower Extremity Wounds, May 11, 2022
Related Publications
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.